Industry Experts

Christopher Yohn, PhD, is Executive Director, Head of Computational Biology at TRex Bio, spearheading the development of the Deep Biology platform for target identification and validation, contributing to therapeutic programs, indication selection, and translational projects. Previously, at UNITY Biotechnology, he directed Discovery Technologies focusing on senolytic approaches for age-related diseases. With a background in biotechnology at Sapphire Energy and bioinformatics at Favrille, he brings expertise in algae-based biofuels and cancer vaccine development. Chris earned his BS from Northwestern University, PhD from The Scripps Research Institute, and completed post-doctoral work at NYU Langone School of Medicine's Skirball Institute of Biomolecular Medicine.